Filing Details
- Accession Number:
- 0001562180-17-003065
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-09-29 18:23:07
- Reporting Period:
- 2017-09-29
- Accepted Time:
- 2017-09-29 18:23:07
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1100412 | Array Biopharma Inc | ARRY | Pharmaceutical Preparations (2834) | 841460811 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1205014 | J Gil Lunsen Van | C/O Array Biopharma Inc. 3200 Walnut Street Boulder CO 80301 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-09-29 | 45,000 | $10.58 | 55,260 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-09-29 | 39,928 | $12.36 | 15,332 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option | Disposition | 2017-09-29 | 45,000 | $0.00 | 45,000 | $10.58 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2010-11-01 | 2017-11-01 | No | 4 | M | Direct |
Footnotes
- This Form 4 is reporting the exercise by the reporting person of an option scheduled to expire on November 1, 2017 and the sale of a portion of the option shares to satisfy payment of the option exercise price.
- The price reported for these shares is the weighted average sale price. Details of actual prices for shares sold are available from the Issuer upon request.
- The option vested in 3 equal annual installments beginning on November 1, 2008.